Introducing the new AltIndexLearn more
$82,000
Est. net congressional buying / selling (2 years). Updated Jul 8, 2026

Are Members of Congress Buying or Selling Biogen?

2 members of the U.S. Congress have traded Biogen (BIIB) stock in the past 90 days, across 2 buys and 1 sell. Congressional trades are reported under the STOCK Act and are typically disclosed within 45 days of the transaction.

Congressional trading is one of the alternative data signals AltIndex tracks as part of the BIIB AI Score. For corporate insider activity, see BIIB insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.

Which Congress Members Are Trading Biogen?

Member of CongressActivityTradesLast Trade
Maria Elvira Salazar Bought $83,000 3 Jun 2, 2026
Ro Khanna Mixed $16,000 2 Nov 15, 2024
Rob Bresnahan Bought $16,000 2 May 15, 2025
Gilbert Cisneros Bought $16,000 2 Jun 5, 2026

BIIB Congressional Trade History

Member of CongressTrade DateTypeEstimated Size
Gilbert Cisneros Jun 5, 2026 Buy $1K – $15K
Maria Elvira Salazar Jun 2, 2026 Sell $15K – $50K
Maria Elvira Salazar May 12, 2026 Buy $1K – $15K
Maria Elvira Salazar May 11, 2026 Buy $50K – $100K
Gilbert Cisneros Jan 30, 2026 Buy $1K – $15K
Rob Bresnahan May 15, 2025 Buy $1K – $15K
Rob Bresnahan Feb 25, 2025 Buy $1K – $15K
Ro Khanna Nov 15, 2024 Buy $1K – $15K
Ro Khanna Sep 9, 2024 Sell $1K – $15K

Frequently Asked Questions: Biogen Congress Trading

In the past 90 days, members of Congress have made 2 purchases and 1 sale of BIIB stock. The net buying may reflect confidence in the stock. Congressional trades are disclosed under the STOCK Act — view the full history on this page.

Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.

Gilbert Cisneros bought Biogen (BIIB) stock most recently, on June 5, 2026.

The estimated net value of congressional trades in Biogen over the past 2 years is positive, at $82,000, meaning members of Congress have on balance bought more than they have sold.

Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.